For the first time, scientists from the University of Delaware College of Health Sciences and the National Institute on Aging ...

FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells ...

Alzinova AB (publ) (ticker: ALZ) today announces that the final analysis of data from the Phase 1b clinical study with the vaccine candidate ALZ-101, which included patients with early Alzheimer's dis ...

The findings suggest that regularly working out in this way could significantly reduce the number of harmful proteins in the ...

Acumen Pharmaceuticals Inc (ABOS) reports robust cash reserves and advances in Alzheimer's research, despite increased R&D expenses and competitive challenges.

Alex Braun; Head of Investor Relations; Acumen Pharmaceuticals Inc. Daniel O'Connell; Chief Executive Officer, Director; Acumen Pharmaceuticals Inc. W. Matthew Zuga; ...

Pomegranates are loaded with antioxidants, fibre, and a variety of vitamins and minerals—all of which are great for your overall health and well-being. According to experts, drinking anaar juice first ...

Discover Acumen Pharmaceuticals' progress on Alzheimer's treatment sabirnetug, Phase 2 trial updates, biomarker advancements, and financial strategies.

Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Rutgers faculty elected to the newest class of fellows of the American Association for the Advancement of Science (AAAS) are ...